No Data
Fangda Carbon New Material plans to invest 1 billion over three years to jointly develop a new generation of carbon-based materials with Jingtai Holdings-P (02228).
Both parties will take AI as the core driving force to carry out deep collaborative innovation in the field of New Materials, promoting the research and development of high-end carbon-based materials and upgrading Intelligent Manufacturing, injecting strong momentum for the implementation of China’s "AI +" national Global Strategy and the construction of new industrialization.
A significant partnership worth over 0.2 billion RMB has been established, opening the door for Crystal Technology Holdings-P (02228) to the trillion-dollar digital economy market in the Middle East.
Jingtai Holdings-P (02228) announced the formal signing of a commercial cooperation agreement with the office of Sheikh Hamad of the UAE royal family in Abu Dhabi to jointly build the first automated traditional medicine modernization research and development laboratory in the Middle East, with an initial investment of up to 30 million USD, equivalent to 0.22 billion yuan.
A strong alliance is advancing AI humanoid robots to empower cell therapy. Crystal Technology Holdings-P (02228), Leimon Biotech, and Yuejiang (02432) are opening a new era of precision medical care.
Recently, Hong Kong stock 18C AI leading company JingTai Holdings-P (02228) and its incubated cellular therapy emerging company LaiMang Biotech will collaborate with Siasun Robot&Automation to establish a joint venture, jointly developing a cellular therapy manufacturing platform based on AI humanoid robots. This cooperation marks the entry of the cellular therapy field into a new stage of intelligence and automation, providing Global patients with more efficient and precise treatment solutions.
Crystal Technology Holdings-P (02228.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
On March 18, Glonghui announced that Crystal Holding-P (02228.HK) will hold a Board of Directors meeting on March 28, 2025, to (include) approve the announcement of the annual results for the year ending December 31, 2024, and to consider the proposal for the final dividend distribution (if any).
Jingtai Holdings-P (02228.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Globe News reported on March 18 that Jingtai Holdings-P (02228.HK) announced that the Board of Directors will hold a meeting on March 28, 2025 (Friday) to consider and approve the group's full-year performance for the year ending December 31, 2024, including the publication of results and a proposal for the final dividend (if any), as well as to address Other matters.
XTALPI-P: DATE OF BOARD MEETING
